Updated September 30, 2022
Inflammatory Bowel Disease includes Crohns Disease, Ulcerative Colitis, and other autoimmune-related bowel dysfunctions (such as with some cases of vasculitis). It does not include non-inflammatory conditions which include Irritable Bowel Syndrome (IBS) of all types or chronic diarrhea or constipation. By virtue of their autoimmune nature, they share immune dysfunction as a part of the root-causes-complex.
IBD’s can be mild with rare episodes, or aggressive, rapidly damaging the lower (and sometimes spreading to the upper) GastroIntestinal Tract (GIT). Older medications such as steroids (cortisone, prednisone) and others such as sulfasalazine can calm the situation down enough to enable time for the holistic approach to ramp up. Sometime the new immune-modulating drugs are necessary. Modalities such as Low Dose Naltrexone (LDN) are being explored by mainstream medicine (such as at the U of Pittsburgh), as well as by the holistic community.
Incorporating strategies for sub-clinical yeast and parasitic infections, toxicities, biofilms, epigenetic modulation and total-body biome (ecology) can improve the rate and depth of healing.
Testing for IBD is not always yielding. Conventional medicine usually offers upper and lower endoscopy (colonoscopy), blood tests, and stool testing. Private labs offer more comprehensive gut testing such as ecological and chemical stool testing.
Efficacy of a Preparation Based on Calcium Butyrate, Bifidobacterium bifidum, Bifidobacterium lactis, and Fructooligosaccharides in the Prevention of Relapse in Ulcerative Colitis–A Prospective Observational Study.2021